Join the 'Terbinex' group to help and get support from people like you.
Posted 4 Nov 2016 by Drugs.com
FRIDAY, Nov. 4, 2016 – Federal health officials say 13 cases of a potentially deadly, drug-resistant fungal infection have been reported in the United States. Four of those cases ended in death, but health officials said it's not clear if the deaths were due to the infection or the patients' underlying health conditions. Candida auris fungal infection is emerging as a health threat worldwide, and it appears to spread in hospitals and other health care facilities, according to the U.S. Centers for Disease Control and Prevention. "We need to act now to better understand, contain and stop the spread of this drug-resistant fungus," CDC Director Dr. Tom Frieden said in an agency news release. "This is an emerging threat, and we need to protect vulnerable patients and others." Of the 13 U.S. cases reported between May 2013 and August 2016, seven are described in the CDC's Nov. 4 Morbidity ... Read more
Related support groups: Infections, Fluconazole, Diflucan, Nystatin, Lamisil, Terbinafine, Clotrimazole, Ketoconazole, Miconazole, Candida Infections, Griseofulvin, Nizoral, Itraconazole, Amphotericin B, Sporanox, Voriconazole, Gris-PEG, Hydroxypropyl Chitosan/terbinafine, Mycostatin, Nilstat
Posted 21 Jan 2016 by Drugs.com
A groundbreaking agreement between the drug industry and governments to work together to fight drug-resistant "superbugs" is expected to be announced Thursday. Under the deal, 74 drug makers, 11 diagnostic test makers, and nine industry groups pledge to work with each other and 16 countries to prevent and improve treatment of drug-resistant infections, the Associated Press reported. These infections are a serious threat to millions of people worldwide and a number of factors contribute to the problem, including overuse of antibiotics, declining drug industry research, and few new medicines to combat bacteria, viruses, parasites and fungi. The new deal – scheduled to be announced at the World Economic Forum in Davos, Switzerland – is the first to outline how the drug industry and governments should team up to prevent more drugs from becoming ineffective, to spur development of new ... Read more
Related support groups: Doxycycline, Cephalexin, Bactrim, Cipro, Ciprofloxacin, Levaquin, Keflex, Sulfamethoxazole, Minocycline, Nystatin, Lamisil, Levofloxacin, Bactrim DS, Cefdinir, Terbinafine, Tetracycline, Avelox, Sulfamethoxazole/Trimethoprim, Cefuroxime, Sulfasalazine